Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: Correlation with enhanced metastatic potential

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 2, 2013, Pages 287-295

  Liu, Hui ^a,b   Chen, Gang ^a   Zhang, Wei ^a   Zhu, Jun Yi ^a   Lin, Zhao Quan ^b   Gong, Zhong Cheng ^b   Wang, Feng Qin ^a   Jia, Jun ^a   Sun, Zhi Jun ^a   Zhao, Yi Fang ^a  

^a WUHAN UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; ISO 1; Metastasis; MIF; p JNK

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; 3 (4 HYDROXYPHENYL) 4,5 DIHYDRO 5 ISOXAZOLEACETIC ACID METHYL ESTER; 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID METHYL ESTER; ISOXAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STAINING; TUMOR INVASION; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; SALIVARY GLAND TUMOR; TUMOR CELL LINE;

CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; ISOXAZOLES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAP KINASE KINASE 4; NEOPLASM METASTASIS; SALIVARY GLAND NEOPLASMS;

MLCS; MLOWN;

EID: 84874971260     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1330-z     Document Type: Article

References (32)

1. Al-Abed Y, VanPatten S (2011) MIF as a disease target: ISO-I as a proof-of-concept therapeutic. Futur Med Chem 3(1):45-63
2. Bach JP, Deuster O et al (2009) The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 115(10):2031-2040
3. Balachandran S, Rodge A et al (2009) Novel derivatives of ISO-1 as potent inhibitors of MIF biological function. Bioorg Med Chem Lett 19(16):4773-4776
4. Bifulco C, McDaniel K et al (2008) Tumor growth-promoting properties of macrophage migration inhibitory factor. Curr Pharm Des 14(36):3790-3801
5. Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26(3):281-285
6. Chen G, Hu X et al (2012) Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis 17(1):90-101
7. Dodd RL, Slevin NJ (2006) Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42(8):759-769
8. Dumitru CA, Gholaman H et al (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129(4):859-869
9. Fridman R, Toth M et al (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22(2-3):153-166
10. Heeren PA, Kloppenberg FW et al (2004) Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus. Anticancer Res 24(4):2579-2583
11. Huang C, Sun Z et al (2012) Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 60(5):793-803
12. Jung H, Seong HA et al (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 283(29):20383-20396
13. Kleemann R, Hausser A et al (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408(6809):211-216
14. Krockenberger M, Engel JB et al (2010) Macrophage migration inhibitory factor expression in cervical cancer. J Cancer Res Clin Oncol 136(5):651-657
15. Liu J, Shao C et al (2011) Molecular biology of adenoid cystic carcinoma. Head Neck. doi: 10.1002/hed.21849
16. Lue H, Dewor M et al (2011) Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23(1):135-144
17. Meyer-Siegler KL, Iczkowski KA et al (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 177(12):8730-8739
18. Nabizadeh Marvast M, Sima HR et al (2011) Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer. J Gastrointest Cancer 42(1):5-10
19. Oda S, Oda T et al (2008) Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE 3(5):e2215
20. Piao S, Zhao S et al (2012) Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 138(4):627-635
21. Qi D, Hu X et al (2009) Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest 119(12):3807-3816
22. Rendon BE, Roger T et al (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282(41):29910-29918
23. Rendon BE, Willer SS et al (2009) Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp Mol Pathol 86(3):180-185
24. Salminen A, Kaarniranta K (2011) Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cell Signal 23(5):747-752
25. Spiro RH (1997) Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174(5):495-498
26. Sun ZJ, Chen G et al (2010a) Activation of PI3 K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 15(7):850-863
27. Sun ZJ, Chen G et al (2010b) Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 334(2):500-512
28. Sun ZJ, Chen G et al (2011) Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol 79(1):106-118
29. Suzuki F, Nakamaru Y et al (2005) Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Oncol Rep 13(1):59-64
30. Tang Y, Liang X et al (2010) Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol 46(4):311-316
31. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537-549
32. Winner M, Koong AC et al (2007) Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res 67(1):186-193